OBJECTIVE: To examine whether frontal lobe abnormalities on magnetic resonance spectroscopy (MRS) in amyotrophic lateral sclerosis (ALS) correlate with poor letter fluency (LF). METHODS: Twenty-five patients with ALS (20 with definite, probable, or possible ALS and 5 with progressive muscular atrophy) performed an LF task, involving F word generation in 1 minute, and underwent MRS. Comparisons were made between patients with ALS with impaired LF and unimpaired LF based on an empirically derived cutoff score. A Spearman correlation was performed between the patient's N-acetyl acetate/creatinine-phosphocreatinine ratio (NAA/Cr) and the number of F words generated. RESULTS: LF was impaired in 50% of patients with ALS. Patients with impaired LF had reduced NAA/Cr in the DLPFC compared with those with unimpaired LF (p = 0.007). There was a significant correlation between LF and NAA/Cr in the DLPFC (r = 0.51, p = 0.0009). The ALS Functional Rating Scale score, clinical region of motor onset, and disease category had no effect on LF or NAA/Cr in the DLPFC. CONCLUSIONS: A reduced NAA/Cr in the DLPFC of patients with ALS is a marker of neuronal dysfunction and correlates with impaired performance on a clinical measure of executive function.
OBJECTIVE: To examine whether frontal lobe abnormalities on magnetic resonance spectroscopy (MRS) in amyotrophic lateral sclerosis (ALS) correlate with poor letter fluency (LF). METHODS: Twenty-five patients with ALS (20 with definite, probable, or possible ALS and 5 with progressive muscular atrophy) performed an LF task, involving F word generation in 1 minute, and underwent MRS. Comparisons were made between patients with ALS with impaired LF and unimpaired LF based on an empirically derived cutoff score. A Spearman correlation was performed between the patient's N-acetyl acetate/creatinine-phosphocreatinine ratio (NAA/Cr) and the number of F words generated. RESULTS:LF was impaired in 50% of patients with ALS. Patients with impaired LF had reduced NAA/Cr in the DLPFC compared with those with unimpaired LF (p = 0.007). There was a significant correlation between LF and NAA/Cr in the DLPFC (r = 0.51, p = 0.0009). The ALS Functional Rating Scale score, clinical region of motor onset, and disease category had no effect on LF or NAA/Cr in the DLPFC. CONCLUSIONS: A reduced NAA/Cr in the DLPFC of patients with ALS is a marker of neuronal dysfunction and correlates with impaired performance on a clinical measure of executive function.
Authors: Joost Raaphorst; Marianne de Visser; Marie-José van Tol; Wim H J P Linssen; Anneke J van der Kooi; Rob J de Haan; Leonard H van den Berg; Ben Schmand Journal: J Neurol Neurosurg Psychiatry Date: 2010-06-18 Impact factor: 10.154
Authors: P Kaufmann; S L Pullman; D C Shungu; S Chan; A P Hays; M L Del Bene; M A Dover; M Vukic; L P Rowland; H Mitsumoto Journal: Neurology Date: 2004-05-25 Impact factor: 9.910
Authors: Sharon Abrahams; Laura H Goldstein; Andy Simmons; Michael J Brammer; Steve C R Williams; Vincent P Giampietro; Chris M Andrew; P Nigel Leigh Journal: Hum Brain Mapp Date: 2003-09 Impact factor: 5.038
Authors: S Abrahams; L H Goldstein; A Simmons; M Brammer; S C R Williams; V Giampietro; P N Leigh Journal: Brain Date: 2004-05-26 Impact factor: 13.501
Authors: Jet M J Vonk; Batool Rizvi; Patrick J Lao; Mariana Budge; Jennifer J Manly; Richard Mayeux; Adam M Brickman Journal: Cereb Cortex Date: 2019-06-01 Impact factor: 5.357
Authors: Anja Mähler; Silvia Mandel; Mario Lorenz; Urs Ruegg; Erich E Wanker; Michael Boschmann; Friedemann Paul Journal: EPMA J Date: 2013-02-18 Impact factor: 6.543
Authors: Daniel Ta; Abdullah Ishaque; Ojas Srivastava; Chris Hanstock; Peter Seres; Dean T Eurich; Collin Luk; Hannah Briemberg; Richard Frayne; Angela L Genge; Simon J Graham; Lawrence Korngut; Lorne Zinman; Sanjay Kalra Journal: Neurology Date: 2021-06-14 Impact factor: 11.800
Authors: Elena Ratti; Kimiko Domoto-Reilly; Christina Caso; Alyssa Murphy; Michael Brickhouse; Daisy Hochberg; Nikos Makris; Merit E Cudkowicz; Bradford C Dickerson Journal: Brain Imaging Behav Date: 2021-02-15 Impact factor: 3.224
Authors: David G Coughlin; Jeffrey S Phillips; Emily Roll; Claire Peterson; Rebecca Lobrovich; Katya Rascovsky; Molly Ungrady; David A Wolk; Sandhitsu Das; Daniel Weintraub; Edward B Lee; John Q Trojanowski; Leslie M Shaw; Sanjeev Vaishnavi; Andrew Siderowf; Ilya M Nasrallah; David J Irwin; Corey T McMillan Journal: Neurobiol Aging Date: 2020-08-21 Impact factor: 4.673
Authors: Fábio Henrique de Gobbi Porto; Lívia Spíndola; Maira Okada de Oliveira; Patrícia Helena Figuerêdo do Vale; Marco Orsini; Ricardo Nitrini; Sonia Maria Dozzi Brucki Journal: Neurol Int Date: 2013-09-05